InVivoMab anti-mouse TIM-3 (CD366)

Catalog number: BE0275_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: Other sizes available
Price: € 3131.00
Expected delivery time: 7 days

Product specifications for - InVivoMab anti-mouse TIM-3 (CD366)

Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Product group: Antibodies
Category: Primary Antibodies
Application: Flow Cytometry; Neutralisation/Blocking
Host: Rat
Clonality: Monoclonal
Isotype: IgG1 Kappa
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: B8.2C12
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab rat IgG1 isotype control (anti-HRP) (BE0088), InVivoMab rat IgG1 isotype control (BE0290)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: B8.2C12; BE0275; BioXCell
Wang HW, Zhu XL, Qin LM, Qian HJ, Wang Y. Microglia activity modulated by T cell Ig and mucin domain protein 3 (Tim-3). Cell Immunol. 2015;293(1):49-58. Read more
Hou H, Liu W, Wu S, et al. Tim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shock. PLoS ONE. 2014;9(10):e110585. Read more
Hongo D, Tang X, Baker J, Engleman EG, Strober S. Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance. Am J Transplant. 2014;14(11):2467-77. Read more
Chabtini L, Mfarrej B, Mounayar M, et al. TIM-3 regulates innate immune cells to induce fetomaternal tolerance. J Immunol. 2013;190(1):88-96. Read more
Hongo D, Tang X, Dutt S, Nador RG, Strober S. Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood. 2012;119(6):1581-9. Read more
Wang F, Wan L, Zhang C, Zheng X, Li J, Chen ZK. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Immunobiology. 2009;214(5):342-9. Read more
Nakae S, Iikura M, Suto H, et al. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood. 2007;110(7):2565-8. Read more
Frisancho-kiss S, Nyland JF, Davis SE, et al. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol. 2006;176(11):6411-5. Read more
Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415(6871):536-41. Read more